These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7899579)
21. Efficacy of safranal to cisplatin-induced nephrotoxicity. Karafakıoğlu YS; Bozkurt MF; Hazman Ö; Fıdan AF Biochem J; 2017 Mar; 474(7):1195-1203. PubMed ID: 28188255 [TBL] [Abstract][Full Text] [Related]
22. The protective effect of 4-hydroxy-2-methyl-N-[2-(tetrazol-5-yl)- phenyl]-2H-1, 2-benzothiazine-3-carboxamide-1, 1-dioxide monosodium salt (HX-1920) on cisplatin-induced toxicity in rats. Shiroshita Y; Minami M; Endo T; Monma Y; Asaka M; Itoh H; Ikeda T; Matsumoto H; Satoh T J Toxicol Sci; 1993 Feb; 18(1):31-41. PubMed ID: 8474148 [TBL] [Abstract][Full Text] [Related]
23. Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin. Carvalho Rodrigues MA; dos Santos NA; da Silva Faria MC; Rodrigues JL; Kinoshita A; Baffa O; Antunes LM; Barbosa F; Gobe GC; dos Santos AC Chem Biol Interact; 2016 Feb; 245():59-65. PubMed ID: 26751708 [TBL] [Abstract][Full Text] [Related]
24. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Yilmaz HR; Iraz M; Sogut S; Ozyurt H; Yildirim Z; Akyol O; Gergerlioglu S Pharmacol Res; 2004 Sep; 50(3):287-90. PubMed ID: 15225672 [TBL] [Abstract][Full Text] [Related]
25. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Naganuma A; Satoh M; Imura N Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104 [TBL] [Abstract][Full Text] [Related]
27. [Detoxifying effect of lisheng-se on cisplatin and its relation to metallothionein induction]. Xu ZL; Guo JH; Song ST Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):280-3. PubMed ID: 7805558 [TBL] [Abstract][Full Text] [Related]
28. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen. Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170 [TBL] [Abstract][Full Text] [Related]
29. Physalis alkekengi and Alhagi maurorum ameliorate the side effect of cisplatin-induced nephrotoxicity. Changizi-Ashtiyani S; Alizadeh M; Najafi H; Babaei S; Khazaei M; Jafari M; Hossaini N; Avan A; Bastani B Cancer Gene Ther; 2016 Jul; 23(7):235-40. PubMed ID: 27255563 [TBL] [Abstract][Full Text] [Related]
30. Protective effect of erythropoietin against cisplatin-induced nephrotoxicity in rats: antigenotoxic and antiapoptotic effect. Rjiba-Touati K; Ayed-Boussema I; Bouaziz C; Belarbia A; Azzabi A; Achour A; Hassen W; Bacha H Drug Chem Toxicol; 2012 Jan; 35(1):89-95. PubMed ID: 21834728 [TBL] [Abstract][Full Text] [Related]
31. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Howell SB; Taetle R Cancer Treat Rep; 1980; 64(4-5):611-6. PubMed ID: 7191778 [TBL] [Abstract][Full Text] [Related]
32. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity. Asna N; Lewy H; Ashkenazi IE; Deutsch V; Peretz H; Inbar M; Ron IG Life Sci; 2005 Mar; 76(16):1825-34. PubMed ID: 15698860 [TBL] [Abstract][Full Text] [Related]
33. Betamipron reduces cisplatin nephrotoxicity in rodents without modifying its antileukemic activity in mice. Tokunaga J; Kobayashi M; Nakamura C; Kitagawa A; Arimori K; Nakano M Ren Fail; 1997 May; 19(3):425-38. PubMed ID: 9154659 [TBL] [Abstract][Full Text] [Related]
34. The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and nitric oxide in cisplatin-induced nephrotoxicity. Gulec M; Iraz M; Yilmaz HR; Ozyurt H; Temel I Toxicol Ind Health; 2006 Apr; 22(3):125-30. PubMed ID: 16716042 [TBL] [Abstract][Full Text] [Related]
35. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity. Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632 [TBL] [Abstract][Full Text] [Related]
36. Improved therapeutic index of cisplatin by procaine hydrochloride. Esposito M; Fulco RA; Collecchi P; Zicca A; Cadoni A; Merlo F; Rosso R; Sobrero A J Natl Cancer Inst; 1990 Apr; 82(8):677-84. PubMed ID: 2319610 [TBL] [Abstract][Full Text] [Related]
37. Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity. Ma SF; Nishikawa M; Hyoudou K; Takahashi R; Ikemura M; Kobayashi Y; Yamashita F; Hashida M Kidney Int; 2007 Dec; 72(12):1474-82. PubMed ID: 17898699 [TBL] [Abstract][Full Text] [Related]
38. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II). Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454 [TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe? Dong Z; Atherton SS Kidney Int; 2007 Jul; 72(1):5-7. PubMed ID: 17597786 [TBL] [Abstract][Full Text] [Related]
40. In vivo effect of copper status on cisplatin-induced nephrotoxicity. Puchkova LV; Skvortsov AN; Rusconi P; Ilyechova EY; Broggini M Biometals; 2016 Oct; 29(5):841-9. PubMed ID: 27481100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]